Pernicious Anemia Treatment: B12 Replacement Therapy Protocols

Pathophysiology

Autoimmune destruction of gastric parietal cells → intrinsic factor deficiency → B12 malabsorption. Also: post-gastrectomy, ileal resection, long-term PPI/metformin.

Treatment Phases

1. Induction (Repletion)

  • Parenteral B12 (cyanocobalamin/hydroxocobalamin): 1000 mcg IM/SC
  • Frequency: Daily × 1 week → weekly × 4 weeks → monthly
  • Alternative: High-dose oral 1000–2000 mcg/day (1% passive absorption bypasses IF)

2. Maintenance

  • IM/SC: 1000 mcg monthly (hydroxocobalamin preferred — longer half-life)
  • Oral: 1000–2000 mcg daily (effective if adherence assured)
  • Nasal gel/spray: Alternative for needle-averse

Monitoring

  • Serum B12, MMA, homocysteine at 1–2 months, then annually
  • CBC/reticulocyte count at 1–2 weeks (reticulocytosis peaks day 5–7)
  • Iron/folate repletion concurrently if deficient
  • Neurologic recovery: months to years; may be incomplete if delayed

Special Populations

  • Pregnancy: Continue parenteral; fetal demand increases
  • Renal impairment: Standard dosing; no accumulation
  • Genetic transcobalamin defects: Different protocol

Blood Disorders - Related Articles